George Soros Dexcom Inc Transaction History

Soros Fund Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $12.9 Million - $16.4 Million	116,800 Added 233.6%	166,800 $18.9 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $6.85 Million - $8.41 Million	-60,000 Reduced 54.55%	50,000 $6.93 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $5.66 Million - $9.31 Million	-75,000 Reduced 40.54%	110,000 $13.6 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $15.9 Million - $25.5 Million	185,000 New	185,000 $17.3 Million
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $49,628 - $70,452	-3,800 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $42,256 - $58,444	3,800	3,800 $218,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Soros Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Soros Fund Management LLC and George Soros with notifications on news.